Seroprevalence of hepatitis B and C virus infections among Lao blood donors

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 38, Issue 4, 2007, Pages 674-679

  Jutavijittum, Prapan ^a   Yousukh, Amnat ^a   Samountry, Bounthome ^b   Samountry, Khamtim ^b   Ounavong, Angkham ^b   Thammavong, Te ^c   Keokhamphue, Jerapha ^c   Toriyama, Kan ^d  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b Lao PDR   (Laos)

^c Lao Red Cross   (Laos)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548274633     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18 (suppl) 1: 20-2.
2. Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J Gastroenterol Hepatol 2004; 19: 665-9.
3. Castillo I, Rodriguez-Inigo E, Lopez-Alcorocho JM, Bartolome J, Pardo M, Carreno V. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection. J Med Virol 2007; 79: 236-41.
4. Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006; 44: 455-61.
5. Jutavijlttum P, Jiviriyawat Y, Yousukh A, et al. A seroepidemiological study on hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in northern Thailand. Jpn J Trop Med Hyg 1999; 27: 13-7.
6. Lavanchy D. Public health measures in the control of viral hepatitis: a World Health Organization perspective for the next millennium. J Gastroenterol Hepatol 2002; 17 (suppl): 452-9.
7. Liu Z, Hou J, Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection, Int J Med Sci 2006; 3; 57-62.
8. Merican I, Guan R, Amarapuka D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15: 1356-61.
9. Ministry of Health, Lao PDR. National immunization program financial sustainability plan: report to the Global Alliance for Vaccines and Immunization, 2002. [Cited on 2007 Mar 14], Available from: URL: http://www.who.int/immunization_financing/countries/lao/en/laopdr_fsp.pdf
10. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005; 92: 607-12.
11. Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 2005; 150: 2513-28.
12. WHO. Hepatitis B. WHO fact sheet No204, 2000a. [Cited on 2007 May 14]. Available from: URL: http://www.who.int/mediacentre/factsheets/fs204/en/ print.html
13. WHO. Hepatitis C. WHO fact sheet No 164, 2000b. [Cited on 2007 May 14]. Available from: URL: http://www.who.int/mediacentre/factsheets/fs164/en/ print.html
14. WHO Regional Office for the Western Pacific. Western pacific regional plan to improve hepatitis B control through immunization, 2003. [Cited on 2007 May 14]. Available from: URL: http://www.wpro.who.int/NR/rdonlyres/ CEDD5D4E71BE-49F4-AEEC-1384751598EE/0/POA_HepB.pdf